EUVIMEDEUVIMED entdecken
Multizentrische StudieOpen Access

Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry

Ibrahim El-Battrawy iD, Katharina Koepsel iD, David Tenbrink, Boldizsar Kovacs iD, Tobias C Dreher iD, Christian Blockhaus iD, Michael Gotzmann iD, Norbert Klein iD, Thomas Kuntz, Dong-In Shin iD, Hendrik Lapp iD, Stephanie Rosenkaimer iD und 10 weitere

Journal of the American Heart Association · 19.09.2023 · 12 (18)

DOI: 10.1161/jaha.123.030615 ↗

Kurz gefasst

Multizentrische Studie in der Zeitschrift Journal of the American Heart Association, erschienen am 19.09.2023. Verfasst von Ibrahim El-Battrawy und 21 weiteren Autor:innen. Beteiligte Einrichtung: Department of Cardiology and Angiology Bergmannsheil University Hospital, Ruhr University of Bochum Bochum Germany. Hauptthemen laut MEDLINE: Myocarditis, Tachycardia, Ventricular, Wearable Electronic Devices. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 18 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background Data on the use of the wearable cardioverter‐defibrillator (WCD) among patients with myocarditis remain sparse. Consequently, evidence for guideline recommendations in this patient population is lacking. Methods and Results In total, 1596 consecutive patients were included in a multicenter registry from 8 European centers, with 124 patients (8%) having received the WCD due to myocarditis and reduced left ventricular ejection fraction or prior ventricular tachyarrhythmia. The mean age was 51.6±16.3 years, with 74% being male. Patients were discharged after index hospitalization on heart failure medication: Angiotensin‐converting enzyme inhibitors (62.5%), angiotensin‐receptor‐neprilysin inhibitor (22.9%), aldosterone‐antagonists (51%), or beta blockers (91.4%). The initial median left ventricular ejection fraction was 30% (22%–45%) and increased to 48% (39%–55%) over long‐term follow‐up ( P

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

MyocarditisTachycardia, VentricularWearable Electronic DevicesHumansMaleAdultMiddle AgedAgedFemaleStroke VolumeVentricular FibrillationVentricular Function, LeftDefibrillators

Stichwörter der Autor:innen

myocarditissudden cardiac deathventricular tachycardiawearable cardioverter‐defibrillator

Autor:innen und Institutionen

  • Department of Cardiology and Angiology Bergmannsheil University Hospital, Ruhr University of Bochum Bochum Germany.
  • Department of Molecular and Experimental Cardiology Institut für Forschung und Lehre (IFL), Ruhr University Bochum Bochum Germany.
  • Department of Cardiology University Heart Center, University Hospital Zurich Zürich Switzerland.
  • Department of Cardiology, Angiology, Haemostaseology and Medical Intensive Care University Medical Center Mannheim, Medical Faculty Mannheim, Heidelberg University Mannheim Germany.
  • Department of Cardiology Heart Centre Niederrhein, Helios Clinic Krefeld Krefeld Germany.
  • Faculty of Health, School of Medicine University Witten/Herdecke Witten Germany.

ORCID-Profile: Ibrahim El-Battrawy, Katharina Koepsel, Boldizsar Kovacs, Tobias C Dreher, Christian Blockhaus, Michael Gotzmann, Norbert Klein, Dong-In Shin, Hendrik Lapp, Stephanie Rosenkaimer, Mohammad Abumayyaleh, Nazha Hamdani, Jacqueline Kowitz, Julia W Erath, Firat Duru, Andreas Mügge, Ibrahim Akin, Thomas Beiert

Zitieren

APA

El-Battrawy, I., Koepsel, K., Tenbrink, D., Kovacs, B., Dreher, T. C., Blockhaus, C., Gotzmann, M., Klein, N., Kuntz, T., Shin, D. I., Lapp, H., Rosenkaimer, S., Abumayyaleh, M., Hamdani, N., Saguner, A. M., Kowitz, J., Erath, J. W., Duru, F., Mügge, A., …, & Beiert, T. (2023). Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry. Journal of the American Heart Association, 12(18). https://doi.org/10.1161/jaha.123.030615

Vancouver

El-Battrawy I, Koepsel K, Tenbrink D, Kovacs B, Dreher TC, Blockhaus C, et al. Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry. Journal of the American Heart Association. 2023;12(18). doi:10.1161/jaha.123.030615

BibTeX
@article{ElBattrawy2023,
  author = {El-Battrawy, Ibrahim and Koepsel, Katharina and Tenbrink, David and Kovacs, Boldizsar and Dreher, Tobias C and Blockhaus, Christian and Gotzmann, Michael and Klein, Norbert and Kuntz, Thomas and Shin, Dong-In and Lapp, Hendrik and Rosenkaimer, Stephanie and Abumayyaleh, Mohammad and Hamdani, Nazha and Saguner, Ardan Muammer and Kowitz, Jacqueline and Erath, Julia W and Duru, Firat and Mügge, Andreas and Akin, Ibrahim and Aweimer, Assem and Beiert, Thomas},
  title = {Use of the Wearable Cardioverter‐Defibrillator Among Patients With Myocarditis and Reduced Ejection Fraction or Ventricular Tachyarrhythmia: Data From a Multicenter Registry},
  journal = {Journal of the American Heart Association},
  year = {2023},
  volume = {12},
  number = {18},
  doi = {10.1161/jaha.123.030615}
}
Kostenlos starten →